Synthesis and evaluation of a monocationic copper(II) radiopharmaceutical derived from N-(2-pyridylmethyl)-N'-(salicylaldimino)- 1,3-propanediamine

Moleephan Sri-Aran, Carla J. Mathias, John K. Lim, Mark A. Green

Research output: Contribution to journalArticle

10 Scopus citations


The monocationic 67Cu complex of N-(2-pyridylmethyl)-N'- (salicylaldimino)-1,3-propanediamine was obtained in high radiochemical purity by reaction of 67Cu2+ with the ligand in ethanol solution. Although this compound exhibited low heart uptake, the desired myocardial retention was observed over the 30 min time period studied in a rat model. Since the octanol/water partition coefficient of [67Cu]Cu(II)-[N-(2- pyridylmethyl)-N'-(salicylaldiminato)-1,3-propanediamine] is lower than a value believed to be the optimal myocardial uptake, it is likely that derivatives of this compound with a higher lipophilicity merit further investigation for use in myocardial imaging with copper radioisotopes.

Original languageEnglish (US)
Pages (from-to)107-110
Number of pages4
JournalNuclear Medicine and Biology
Issue number2
StatePublished - Feb 1 1998



  • Copper-62
  • Copper-67
  • Myocardial imaging

ASJC Scopus subject areas

  • Molecular Medicine
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this